Ronald Perrone

Training + Education

Hahnemann Medical College of Philadelphia; Boston University Medical Center; Emory University Medical Center; Grady Memorial Hospital

Board Certifications

Internal Medicine, Nephrology

Honors + Awards

• 2018, "Top Doctor," Boston Magazine
• 2017, "Top Doctor," Boston Magazine
• 2017, Lillian Jean Kaplan International Prize, International Society of Nephrology
• 2015, "Top Doctor," Boston Magazine
• 2014, Physician of the Year from the Polycystic Kidney Disease Foundation
• 2014, Donald W. Seldin Distinguished Award from the National Kidney Foundation
• 2013, Top Doctor Boston Magazine
• 2012, "Top Doctor," Boston Magazine
• 2012, "Top Doctor" and in top 1% in the nation in his specialty, U.S. News & World Report
• 2009 Distinguished Faculty Award from TUSM
• 2007 Gift of Life Award - Outstanding Physician in Nephrology, National Kidney Foundation of MA, RI, NH and VT
• 2002, Citation for Excellence in Teaching by the Class of 2002 Tufts University School of Medicine
• 2001-2002 Tufts University School of Medicine Excellence in Teaching Award from the Third Year Medical Students
• 2000-2001, Tufts University School of Medicine Excellence in Teaching Award from the Third Year Medical Students

Publications + National Presentations

1. Perrone RD, Abebe KZ, Schrier RW, Chapman AB, Torres VE, Bost J, Kaya D, Miskulin DC, Steinman TI, Braun W, Winklhofer FT, Hogan MC, Tahbari-Oskoui F, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin D, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Bae KT; HALT PKD Study Group, Meyers CM. Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2011;6:2508-15. Epub 2011 Sept 8.

2. Grantham JJ, Bennett WM, mTOR inhibitors and autosomal dominant polycystic kidney disease. N Engl J Med 2011;364:286-7; author reply 287-9.

3. Vora, N, Perrone, R, Bianchi, DW. Reproductive issues for adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD). Am J Kidney Dis 2008;51:307-18.

4. Alam A, Perrone, RD. Managing cyst infections in ADPKD: an old problem looking for answers. Clin J Am Soc Nephrol; 4:1154-1155, 2009.

5. Chapman, AB, Torres VE, Perrone RD, Steinman TI, Bae KT, Miller JP, Miskulin DC, Oskoui FR, Masoumi A, Hogan MC, Winklhofer FT, Braun W, Thompson PA, Meyers CM, Schrier RW. The Halt Polycystic Kidney Disease Trials: design and implementation. Clin J Am Soc Nephrol;5102-9,2010.

6. Alam A, Perrone RD. Management of the ESRD in patients with autosomal dominant polycystic kidney disease. Adv Chron Kid Dis;17:164-172,2010.

7. Grantham JJ, Bennett WM, Perrone RD. mTOR inhibitors and automal dominant polycystic kidney disease. N Engl J Med; 364:286-287; author reply 287-289,2011.

8. Heffernan KS, Kuvin JT, Sarnak MJ, Perrone RD, Miskulin DC, Rudym D, Chandra P, Karas RH, Menon V. Peripheral augmentation index and vascular inflammation in autosomal dominent polycystic kidney disease. Nephrol Dial Transpl; epublication February 3, 2011.

Professional Memberships

• Member, Scientific Advisory Committee (former Chairperson), Polycystic Kidney Disease Foundation
• Member, Board of Trustees, Polycystic Kidney Disease Foundation
• Region 1 Representative, OPTN/UNOS Kidney Transplant Committee
• Chair, UNOS Region 1 Renal Transplant Oversight Committee.
• Editorial Board, Clinical Journal of the American Society of Nephrology